[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522559":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":36,"responsibleParty":53,"collaborators":20,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":20,"enrollmentInfo":64,"targetDuration":20,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":39,"whyStopped":20,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Institut du Cancer de Montpellier - Val d'Aurelle","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single arm","EXPERIMENTAL","single arm",[13],"Biological: Blood sample and tissue sample",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BIOLOGICAL","Blood sample and tissue sample","During the surgery :\n\n* Tissus sample : primary tumor and metastasis\n* blood sample : 3 EDTA tubes\n* ex vivo MRI data",[9],null,[22],{"name":23,"affiliation":24,"role":25},"NOUGARET Stephanie, MD","INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier","STUDY_DIRECTOR",[27,33],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"MOUSSION Aurore","CONTACT","0467613102","+33","aurore.moussion@icm.unicancer.fr",{"name":34,"role":29,"phone":30,"phoneExt":31,"email":35},"Texier Emmanuelle","emmanuelle.texier@icm.unicancer.fr",[37],{"facility":38,"status":39,"city":40,"state":20,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"NOUGARET Stephanie","RECRUITING","Montpellier","34298","France","FR",{"type":45,"coordinates":46},"Point",[47,48],3.87635,43.61093,{"lat":48,"lon":47},[51],{"name":23,"role":29,"phone":20,"phoneExt":20,"email":52},"stephanie.nougaret@icm.unicancer.fr",{"type":54,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100522559","unravelling-tumour-biology-in-ovarian-cancer-with-precision-imaging-100522559",false,"NCT06084195","Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging","MR-O-MICS","Inclusion Criteria:\n\n* Patient aged \\>18\n* Pathologically proven HGSOC at an advanced stage (FIGO IIIB or IIIC) which can benefit from surgery with or without prior neoadjuvant treatment\n* Willingness and ability to comply with planned visits, treatment plan, laboratory tests and other study procedures,\n* Patient who has given informed, written and express consent,\n* Patient affiliated with a French health insurance scheme.\n\nExclusion Criteria:\n\n* Early-stage disease (FIGO \\\u003CIIIB) or presence of extraperitoneal metastases,\n* Patient who will not have surgery\n* Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons,\n* Patient under guardianship, curatorship or safeguarding of justice,\n* Pregnant and\u002For nursing patient,\n* Patient with a history of other cancers within 5 years\u002F10 years prior to inclusion","FEMALE","18 Years",{"count":65,"type":66},120,"ESTIMATED","INTERVENTIONAL",[69],"NA","The objective of this study is to explore the integration of in vivo and ex vivo of MRI with histology and molecular assessments to advance non-invasive characterization of tumor heterogeneity in high-grade serous ovarian cance",[72],"High Grade Serous Ovarian Cancer",[74,75,76,77,78],"Radiomics","Ovarian cancer","Genomics","Proteomics","Immune Tumor Microenvironment","2025-02-11",{"date":81,"type":82},"2025-02-12","ACTUAL",{"date":84,"type":82},"2023-12-19",{"date":86,"type":66},"2029-10",{"name":5,"class":6},1]